Stem Cell Therapy Market by Treatment Mode & Therapeutic Applications worth $330 Million in 2020 - New Report by MarketsandMarkets

Share Article

A number of factors such as increasing funding from various government and private organizations, growing industry focus on stem cell research, and rising global awareness about stem cell therapies through various organizations are driving the growth of the global market.



Key Players are Mesoblast Ltd. (Australia), Aastrom Biosciences Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.)

The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).

Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC.

Early buyers will receive 10% customization on this report.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330 million by 2020

Inquire Before Buying @

A number of factors such as the increasing funding from various government and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are stimulating the research activities for stem cell therapies. Developing markets, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies represent high growth opportunities for market players.

Buy NOW!

StemCells, Inc. (U.S.) is also one of the significant players involved in the development of stem cell therapy products. It is engaged in the research, development, and commercialization of stem cell therapeutics for academia and industry. The company focuses on development and commercialization of stem cells and progenitor cells based novel therapies as well as related tools and technologies. This strategy enables StemCells, Inc. to maintain its position among the key players in the stem cell therapy market.

Approval of clinical trials and products, partnerships, agreements, collaborations, and joint ventures are the key growth strategies adopted by leading industry participants. Market players adopted these strategies to access new technologies, commercialize their products in short term, gain regulatory approvals, and/or increase their market visibility.

In 2015, North America will hold the largest share of the global stem cell therapy market. This large share is primarily attributed to the extensive government funding and increasing fast-track approval for stem cell therapeutics by the FDA. Moreover, development of advanced genomic methods for stem cell analysis and high number of ongoing research activities are further fuelling the growth of the stem cell therapy market in North America. However, the Asia-Pacific stem cell therapy market is expected to grow at the highest CAGR in the forecast period, owing to factors such as increasing regulatory support through favourable government policies, strong product pipelines, and increasing licensing activities in this region.

The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and Stem Cells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.

Browse Related Reports:

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)

Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets [email protected]
Connect with us on [email protected]

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
Follow us on
Visit website